Table 1.
Study | Outcome | N | Duration | Design | Comparison | SFA replaced by | |||
---|---|---|---|---|---|---|---|---|---|
PUFA | MUFA | TFA | CHO | ||||||
Margetts et al. [26] | Blood pressure | 54 | 6 weeks | Cross-over | 18%E SFA versus 15%E PUFA | ↔ | |||
Puska et al. [27] | Blood pressure | 84 | 12 weeks | Parallel | 11%E SFA versus 8%E PUFA | ↔ | |||
Sacks et al. [28] | Blood pressure | 21 | 6 weeks | Cross-over | 16%E SFA versus 14%E PUFA or 52%E CHO | ↔ | ↔ | ||
Storm et al. [29] | Blood pressure | 15 | 3 weeks | Cross-over | 13%E 18:0 SFA versus 16%E 16:0 SFA or 51%E CHO | ↔ | |||
Piers et al. [30] | Blood pressure | 8 | 4 weeks | Cross-over | 24%E SFA versus 23%E MUFA | ↔ | |||
Sanders et al. [31] | Blood pressure | 110 | 6 months | Parallel | 17%E SFA versus 17%E MUFA or CHOa | ↔ | ↔ | ||
Uusitupa et al. [33] | Blood pressure | 159 | 6 months | Parallel | 14%E SFA vs. 8%E PUFA, 11%E MUFA, or 53%E CHO | ↔ | ↔ | ↔ | |
Lahoz et al. [32] | Blood pressure | 42 | 5 weeks | Consecutive diets-non randomized | 17%E SFA versus 21%E MUFA or 13%E PUFA | ↓ | ↓ | ||
Rasmussen et al. [34] | Blood pressure | 162 | 3 months | Parallel | 18%E SFA versus 21%E MUFA | ↓ | |||
de Roos et al. [35] | Endothelial function – FMD | 29 | 4 weeks | Cross-over | 23%E SFA versus 9%E TFA | ↓ | |||
Fuentes et al. [36] | Endothelial function – FMD | 22 | 4 weeks | Cross-over | 20%E SFA versus 22%E MUFA or 57%E CHO | ↑ | ↔ | ||
Keogh et al. [37] | Endothelial function – FMD | 40 | 3 weeks | Cross-over | 19%E SFA versus 19%E MUFA, 10%E PUFA, or 65%E CHO | ↑ | ↑ | ↑ | |
Sanders et al. [31] | Endothelial function – FMD | 110 | 6 months | Parallel | 17%E SFA versus 17%E MUFA or CHOa | ↔ | ↔ | ||
Keogh et al. [37] | Arterial stiffness – PWV | 40 | 3 weeks | Cross-over | 19%E SFA versus 19%E MUFA, 10%E PUFA, or 65%E CHO | ↔ | ↔ | ↔ | |
Sanders et al. [31] | Arterial stiffness – PWV | 110 | 6 months | Parallel | 17%E SFA versus 17%E MUFA or CHOa | ↔ | ↔ |
Direction of effect on reported outcome (↑ increased; ↓ decreased; ↔ no effect)
CHO carbohydrate, MUFA monounsaturated fatty acids, FMD brachial artery flow-mediated dilatation, PUFA polyunsaturated fatty acids, PWV pulse wave velocity, SFA saturated fatty acids, TFA trans fatty acids, %E percentage of total energy intake
a%E not reported